January 4, 2022
Beijing, China, December 6th, 2021 – Sino Biological Inc. (https://www.sinobiological.com; SHE: 301047) announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-COV-2 virus, which quickly raised concerns around the world because of the high number of mutations it carries, especially the 30-plus mutations on the [...]
Quantum-Si Signs Lease for New Headquarters in New Haven
January 4, 2022
Quantum-Si will begin relocating to the landmark Winchester Works site in the first half of 2022 GUILFORD, Conn. -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it has entered into a lease agreement with Winchester Office LLC to develop a [...]
January 4, 2022
LOS ANGELES -- Calibre Scientific is pleased to announce the acquisition of AmpliTech, a distributor of reagents and instruments to research and diagnostic laboratories with headquarters in Compiègne, France. AmpliTech further enhances Calibre Scientific’s growing distribution platform in Europe. Founded in 1996, AmpliTech specializes in molecular pathology, cytogenetics, and molecular genetics (prenatal, postnatal, and oncology). The Company [...]
Genomenon and OmniTier Partner to Bring Mastermind’s Evidence Sources to CompStor Insight
January 4, 2022
High Throughput, On-Premises Variant Interpretation Appliance Provides Advanced AI and Data Acceleration Technologies for Genomics Applications Genomenon, Inc.®, an AI-driven genomics company, announced a partnership with OmniTier, which includes integration of the Mastermind® Genomic Search Engine into their on-premises based CompStor Insight® genomics analysis platform. This integration will allow CompStor® users to preview the number of published articles related to their search [...]
DNA Script Closes $200 Million Series C Financing with Completion of Second Tranche
January 4, 2022
Accounts and funds advised by T. Rowe Price Associates, Inc. and Baillie Gifford join syndicate of investors Funding to accelerate commercial launch of revolutionary enzymatic DNA printing technology SOUTH SAN FRANCISCO, Calif., and PARIS -- DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) for on-demand DNA printing, today announced the completion of its Series C financing, [...]
January 4, 2022
Illumina and Syapse Partner on Research to Evaluate Large Panel Biomarker Testing Patterns Across US Community Oncology Practices The collaboration will explore the uptake and actionability of comprehensive genomic profiling in patients with advanced cancers. San Francisco, CA – Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases [...]
Alamar Biosciences partners with Abcam to drive understanding of the human proteome
January 4, 2022
Alamar selects Abcam as a key provider of antibody content for its propriety NULISA technology platform Fremont, CA, US and Cambridge, UK – Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences research tools, [...]
GeneASIC Applied sciences to Exhibit New Genome Knowledge Evaluation System at CES 2022
January 4, 2022
LAS VEGAS — GeneASIC Applied sciences might be strolling into this 12 months’s CES 2022 arm in arm with its first product, the GeneASIC Subsequent-Technology Sequencing Evaluation Acceleration Platform (NGSAAP). The annual occasion deemed probably the most influential tech occasion and is a showcase of the most recent innovation in design and engineering within the client know-how [...]
January 4, 2022
The CentoCloud solution is a cloud-based Software as a Service (SaaS) platform that enables laboratories around the world to analyze, interpret, and report genomic variants, and will be able to utilize the power of proprietary reagent kits CENTOGENE is developing in collaboration with Twist Bioscience for rare disease diagnostics CentoCloud provides rapid and reliable medical [...]
eureKARE participates in DNA Script’s $200 Million Series C Financing
January 4, 2022
eureKARE participatesin DNA Script’s $200 Million Series C Financing Fundraisewill accelerate commercial launch of revolutionary enzymatic DNA printing technology Luxembourg and Paris, France – eureKARE ("the Company"), a pioneering company focused on financing and building next generation biotechnology companies in the disruptive fields of the microbiome and synthetic biology, is pleased to announce that it has participated in DNA Script’s [...]
